Prevalence of obesity among U.S. population with substance dependence.
Adolescent
Adult
Aged
Alcoholism
/ diagnosis
Amphetamine-Related Disorders
/ diagnosis
Child
Cross-Sectional Studies
Drug Users
Female
Health Surveys
/ methods
Heroin Dependence
/ diagnosis
Humans
Male
Marijuana Abuse
/ diagnosis
Middle Aged
National Institute on Drug Abuse (U.S.)
/ trends
Obesity
/ diagnosis
Prevalence
Substance-Related Disorders
/ diagnosis
Tobacco Use Disorder
/ diagnosis
United States
/ epidemiology
Alcohol dependence
Heroin dependence
Marijuana dependence
Nicotine dependence
Obesity
Stimulant dependence
Journal
Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
received:
23
06
2020
revised:
03
09
2020
accepted:
05
09
2020
pubmed:
28
9
2020
medline:
13
4
2021
entrez:
27
9
2020
Statut:
ppublish
Résumé
To investigate associations between substance dependence and obesity. Obesity (body mass index ≥ 30 kg/m It was estimated that 10.6 % of noninstitutional U.S. residents aged 12 years or older were nicotine-dependent, 3.0 % alcohol-dependent, 1.0 % marijuana-dependent, 0.6 % stimulant-dependent, and 0.2 % heroin-dependent. Heroin-dependent individuals had 59 % lower odds of obesity relative to their non-dependent counterparts (AOR = 0.41; 95 % CI: 0.28-0.60; p < 0.0001). Lower odds of obesity were also noted for marijuana-dependent (AOR = 0.64; 95 % CI: 0.56-0.73; p < 0.0001), nicotine-dependent (AOR = 0.68; 95 % CI: 0.64-0.72; p < 0.0001) and alcohol-dependent (AOR = 0.77, 95 % CI: 0.69-0.84; p < 0.0001) individuals, but not statistically significant for stimulant-dependent individuals (AOR = 0.84; 95 % CI: 0.68-1.02; p = 0.0825). Heroin, marijuana, nicotine and alcohol dependence were associated with lower odds of obesity than their non-dependence counterparts. Main findings based on 2015-2017 NSDUH are consistent with findings from our prior report based on clinical trials data from National Institute on Drug Abuse Clinical Trials Network, and other epidemiological evidence in the literature. These findings can alert substance abuse treatment professionals to monitor weight change, especially among weight-concerned substance abusers.
Identifiants
pubmed: 32980787
pii: S0376-8716(20)30458-0
doi: 10.1016/j.drugalcdep.2020.108293
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108293Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.